Northwest Biotherapeutics (QB) Stock Price

0.08 (4.21%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Northwest Biotherapeutics Inc (QB) NWBO OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.08 4.21% 1.98 16:59:23
Close Price Low Price High Price Open Price Previous Close
1.98 1.93 2.09 1.98 1.90
Bid Price Ask Price Spread News
1.50 2.19 0.69 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,944 6,365,644 $ 1.9896 $ 12,665,158 6,753,987 0.005 - 2.54
Last Trade Time Type Quantity Stock Price Currency
16:00:13 formt 5,000 $ 1.98 USD

Northwest Biotherapeutics (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.51B 762.56M 657.93M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
16.59M $ - 0.00% - -

more financials information »

Northwest Biotherapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NWBO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.552.541.461.9319,691,9820.4327.74%
1 Month0.78212.540.6521.459,536,3431.20153.16%
3 Months0.352.540.0051.026,911,3741.63465.71%
6 Months0.17992.540.0050.81571344,537,9741.801,000.61%
1 Year0.23492.540.0050.66963313,015,1951.75742.91%
3 Years0.172.540.0050.46947291,947,4011.811,064.71%
5 Years0.52752.540.0050.42430481,893,9311.45275.36%

Northwest Biotherapeutics (QB) Description

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.